Literature DB >> 32053308

Unfolding Discoveries in Heart Failure.

Walter J Paulus1.   

Abstract

Entities:  

Year:  2020        PMID： 32053308     DOI： 10.1056/NEJMcibr1913825

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction.

Authors:  Gabriele G Schiattarella; Pilar Alcaide; Gianluigi Condorelli; Thomas G Gillette; Stephane Heymans; Elizabeth A V Jones; Marinos Kallikourdis; Andrew Lichtman; Federica Marelli-Berg; Sanjiv Shah; Edward B Thorp; Joseph A Hill
Journal:  Nat Cardiovasc Res       Date:  2022-03-14

2.  Obesity and HFpEF.

Authors:  Francesco Clemenza; Roberto Citarrella; Angelo Patti; Manfredi Rizzo
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

3.  Metabolic inflammation in heart failure with preserved ejection fraction.

Authors:  Gabriele G Schiattarella; Daniele Rodolico; Joseph A Hill
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

Review 4.  Cellular and molecular pathobiology of heart failure with preserved ejection fraction.

Authors:  Sumita Mishra; David A Kass
Journal:  Nat Rev Cardiol       Date:  2021-01-11       Impact factor: 49.421

Review 5.  Acromegaly, inflammation and cardiovascular disease: a review.

Authors:  Thalijn L C Wolters; Mihai G Netea; Niels P Riksen; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

6.  Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction.

Authors:  Gabriele G Schiattarella; Francisco Altamirano; Soo Young Kim; Dan Tong; Anwarul Ferdous; Hande Piristine; Subhajit Dasgupta; Xuliang Wang; Kristin M French; Elisa Villalobos; Stephen B Spurgin; Maayan Waldman; Nan Jiang; Herman I May; Theodore M Hill; Yuxuan Luo; Heesoo Yoo; Vlad G Zaha; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Nat Commun       Date:  2021-03-16       Impact factor: 17.694

7.  Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.

Authors:  Virginia S Hahn; Hildur Knutsdottir; Xin Luo; Kenneth Bedi; Kenneth B Margulies; Saptarsi M Haldar; Marina Stolina; Jun Yin; Aarif Y Khakoo; Joban Vaishnav; Joel S Bader; David A Kass; Kavita Sharma
Journal:  Circulation       Date:  2020-10-29       Impact factor: 29.690

Review 8.  Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects.

Authors:  Giuseppe Palmiero; Arturo Cesaro; Erica Vetrano; Pia Clara Pafundi; Raffaele Galiero; Alfredo Caturano; Elisabetta Moscarella; Felice Gragnano; Teresa Salvatore; Luca Rinaldi; Paolo Calabrò; Ferdinando Carlo Sasso
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

9.  Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.

Authors:  Di Chang; Ting-Ting Xu; Shi-Jun Zhang; Yu Cai; Shu-Dan Min; Zhen Zhao; Chun-Qiang Lu; Yuan-Cheng Wang; Shenghong Ju
Journal:  Exp Biol Med (Maywood)       Date:  2021-08-03

Review 10.  Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach.

Authors:  Antoni Bayes-Genis; Felipe Bisbal; Julio Núñez; Enrique Santas; Josep Lupón; Patrick Rossignol; Walter Paulus
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.